MAPS Act
Latest action (Mar 19, 2026) — Committee on Health, Education, Labor, and Pensions. Hearings held.
What it does
Congressional Research Service, May 15, 2025Mapping America’s Pharmaceutical Supply Act or the MAPS Act
This bill requires the Food and Drug Administration (FDA) to continually update its essential medicines list and identify risks and vulnerabilities in the associated supply chains.
In 2020, in response to an executive order, the FDA published a list of essential medicines deemed medically necessary to have available at all times. The bill requires the FDA to update and maintain this list to include drugs and ingredients (1) related to responding to public health threats and emergency incidents, (2) of greatest priority for providing health care and at high risk of shortage, (3) the shortage of which would adversely affect patients with chronic conditions, and (4) that the Department of Defense (DOD) determines to be critical for military preparedness. The FDA must update the list at least every two years.
Also, the bill requires the FDA to conduct a risk assessment of the supply chains for drugs and ingredients on the list and annually report its findings to Congress. The assessment must include information about key manufacturing materials, drugs with primarily foreign suppliers, manufacturing capacity, relevant public health and national security risks, and risk mitigation strategies.
Additionally, the Department of Health and Human Services, in coordination with other agencies, must map and monitor relevant supply chains to identify vulnerabilities and provide an annual status report to Congress.
Finally, DOD must report to Congress every 180 days on the drugs DOD purchased that were manufactured in or sourced from China.
Face Value
as introducedHow much of this bill its name accounts for.
- Every bill starts at100
- Areas of law−8
Amends 2 titles of the US Code (5 and 18) rather than one.
Face Value measures reach, not honesty. A big bill can be accurately named, and a low score is not an accusation — it means the contents reach further than any short title could describe. Count it yourself ↗ How this is worked out
Who lobbied on this
4 organizationsThese organizations told Congress, in their own quarterly disclosures, that they were lobbying on this bill.
- American Association of Oral and Maxillofacial Surgeonswanted it passed
“…ramp up their production capacity if necessary to proactively prevent shortages. -Support for the Mapping Americas Pharmaceutical Supply or MAPS Act (S 1784/HR 4191), which seeks conduct a risk assessment and supply chain map of all essential medicines to help identify vulnerabilities and potential…” filing ↗
- Vizient, Inc.wanted it passed
“…passage of the Save Healthcare Workers Act (H.R.3178/S.1600) Endorsed passage of the Mapping Americas Pharmaceutical Supply (MAPS) Act (H.R.4191/S.1784) Hospital Group Purchasing - Advocated to highlight the value that hospital group purchasing organizations provide to hospitals and suppliers.…” filing ↗
- American Hospital Associationno position stated
“…S. 1784 / H.R. 4191, The Mapping America's Pharmaceutical Supply (MAPS) Act, all…” filing ↗
- Pharmaceutical Research & Manufacturers of Americano position stated
“…932: Give Kids a Chance Act of 2025 S. 1302: Increasing Transparency in Generic Drug Applications Act S. 1414: Expedited Acccess to Biosimilars Act S. 1784: MAPS Act S. 2780: Medication Affordability and Patent Integrity Act S. 1954: Biosimilar Red Tape Elimination Act H.R. 1: One Big Beautiful…” filing ↗
Most filings say only that an organization lobbied on a bill, not which side it took — where that's the case we say so rather than guessing. Quotes are verbatim from the filing. How this is built.
Discussion
0 commentsSign in to join the discussion and put your vote on the record.
No comments yet. Be the first to make the case.